Axiom Capital Sees Polypore International as Overvalued

Loading...
Loading...
In a report published Friday, Axiom Capital analyst Gordon L. Johnson II reiterated a Sell rating and $16.00 price target on
Polypore InternationalPPO
. In the report, Axiom Capital noted, “PPO is among the most overvalued & cheered Wall Street stocks in the market today, currently trading at a 27x & 20x P/E multiple on ‘14 & ‘15 Consensus ests., despite the fact that core op. profit fell to just $110mn in '13 vs. $180mn in '11; while PPO remains grossly overvalued on current val. multiples, driven by mistruths about its position w/ both Panasonic & Samsung, it's now time to ‘show & prove' on the EPS line.” Polypore International closed on Thursday at $37.23.
Market News and Data brought to you by Benzinga APIs
Posted In: Analyst ColorReiterationAnalyst Ratingsaxiom capitalGordon L. Johnson II
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...